Morgan Stanley Smith Barney proposes sale of ABBV shares

Morgan Stanley Smith Barney LLC submitted a Form 144 notice concerning proposed sales of Common shares of ABBV (listed NYSE).

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 notice concerning proposed sales of Common shares of ABBV (listed NYSE). The filing lists multiple tranches of Restricted Stock and Performance Shares with date labels and per‑lot quantities such as 426, 392, 377, 293, 386, 496, 1,543, and 1,317. The cover shows a filing date of 03/04/2026.

Insights

Securities Compliance Analyst

Form 144 lists proposed broker-facilitated sales of ABBV restricted and performance shares.

The notice identifies the filer as Morgan Stanley Smith Barney LLC and enumerates proposed sale lots by grant date and instrument type, including restricted stock and performance shares with specific lot quantities (for example, 426 and 1,543).

Timing and proceeds details are not provided in the excerpt; subsequent trade execution and reporting would determine actual transfers and any impact on outstanding share count.

FAQ

What does the ABBV Form 144 filed by Morgan Stanley Smith Barney LLC mean?

It indicates a proposed sale of ABBV common shares by Morgan Stanley Smith Barney LLC. The filing lists specific restricted and performance share lots, with a cover date of 03/04/2026, but it is a notice of intent rather than proof of sale.

Which types and quantities of ABBV securities are listed in the filing?

The excerpt lists Restricted Stock and Performance Shares across several grant dates. Example quantities include 426, 392, 377, 293, 386, 496, 1,543, and 1,317 associated with those dates.

Who is the filer on the ABBV Form 144 and where is the stock listed?

The filer is identified as Morgan Stanley Smith Barney LLC with an address at New York Plaza; the security is listed on the NYSE. The filing cover date shown is 03/04/2026.

Does the Form 144 confirm that the ABBV shares were sold?

No. Form 144 provides notice of an intended sale under Rule 144; it does not confirm execution. Actual sales and settlement would be reported separately through trade confirmations and regulatory filings if completed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 05:04 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002057696
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ABBVIE INC.
SEC File Number	001-35565
Address of Issuer	1 NORTH WAUKEGAN ROAD NORTH CHICAGO ILLINOIS 60064
Phone	847-938-6166
Name of Person for Whose Account the Securities are To Be Sold	David R. Purdue
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	5230	1221518.80	1768169012	03/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/18/2023	Restricted Stock	Issuer			426	02/18/2023	Compensation
Common	02/18/2024	Restricted Stock	Issuer			392	02/18/2023	Compensation
Common	02/17/2023	Restricted Stock	Issuer			377	02/17/2023	Compensation
Common	02/17/2024	Restricted Stock	Issuer			293	02/17/2024	Compensation
Common	02/17/2025	Restricted Stock	Issuer			386	02/17/2025	Compensation
Common	02/28/2024	Performance Shares	Issuer			496	02/28/2024	Compensation
Common	02/28/2025	Performance Shares	Issuer			1543	02/28/2025	Compensation
Common	02/28/2026	Performance Shares	Issuer			1317	02/28/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ T.O. Odutayo, Attorney-in-Fact for David R. Purdue
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)